BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 23033370)

  • 1. Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone/salt-treated mice.
    Chan CT; Moore JP; Budzyn K; Guida E; Diep H; Vinh A; Jones ES; Widdop RE; Armitage JA; Sakkal S; Ricardo SD; Sobey CG; Drummond GR
    Hypertension; 2012 Nov; 60(5):1207-12. PubMed ID: 23033370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.
    Wang Y; Zhu M; Xu H; Cui L; Liu W; Wang X; Shen S; Wang DH
    Exp Biol Med (Maywood); 2015 Sep; 240(9):1223-34. PubMed ID: 25585624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M2 macrophage accumulation in the aortic wall during angiotensin II infusion in mice is associated with fibrosis, elastin loss, and elevated blood pressure.
    Moore JP; Vinh A; Tuck KL; Sakkal S; Krishnan SM; Chan CT; Lieu M; Samuel CS; Diep H; Kemp-Harper BK; Tare M; Ricardo SD; Guzik TJ; Sobey CG; Drummond GR
    Am J Physiol Heart Circ Physiol; 2015 Sep; 309(5):H906-17. PubMed ID: 26071547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of transient receptor potential vanilloid type 1 and C-C chemokine receptor 2 in renal injury induced by salt-sensitive hype].
    Zhu FY; Liu WH; Wang XX; Cui L; Shen S; Zhu MJ; Wang YP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Oct; 36(5):488-95. PubMed ID: 25360645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of chemokine receptor 2 in renal damage induced by deoxycorticosterone acetate-salt hypertension].
    Sun M; Cui L; Liu WH; Gao Y; Shen S; Zhu MJ; Wang YP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):29-35. PubMed ID: 23469787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure.
    Rickard AJ; Morgan J; Tesch G; Funder JW; Fuller PJ; Young MJ
    Hypertension; 2009 Sep; 54(3):537-43. PubMed ID: 19635989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.
    Carneiro FS; Nunes KP; Giachini FR; Lima VV; Carneiro ZN; Nogueira EF; Leite R; Ergul A; Rainey WE; Clinton Webb R; Tostes RC
    J Sex Med; 2008 Dec; 5(12):2793-807. PubMed ID: 18823320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CCL2/CCL7/CCL12/CCR2 pathway is substantially and persistently upregulated in mice after traumatic brain injury, and CCL2 modulates the complement system in microglia.
    Popiolek-Barczyk K; Ciechanowska A; Ciapała K; Pawlik K; Oggioni M; Mercurio D; De Simoni MG; Mika J
    Mol Cell Probes; 2020 Dec; 54():101671. PubMed ID: 33160071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Necrosis Factor Alpha Deficiency Improves Endothelial Function and Cardiovascular Injury in Deoxycorticosterone Acetate/Salt-Hypertensive Mice.
    Cai R; Hao Y; Liu YY; Huang L; Yao Y; Zhou MS
    Biomed Res Int; 2020; 2020():3921074. PubMed ID: 32190663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.
    Raghu H; Lepus CM; Wang Q; Wong HH; Lingampalli N; Oliviero F; Punzi L; Giori NJ; Goodman SB; Chu CR; Sokolove JB; Robinson WH
    Ann Rheum Dis; 2017 May; 76(5):914-922. PubMed ID: 27965260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of CCR2 reduces macrophage influx and development of chronic renal damage in murine renovascular hypertension.
    Kashyap S; Warner GM; Hartono SP; Boyilla R; Knudsen BE; Zubair AS; Lien K; Nath KA; Textor SC; Lerman LO; Grande JP
    Am J Physiol Renal Physiol; 2016 Mar; 310(5):F372-84. PubMed ID: 26661648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension.
    Callera GE; Touyz RM; Teixeira SA; Muscara MN; Carvalho MH; Fortes ZB; Nigro D; Schiffrin EL; Tostes RC
    Hypertension; 2003 Oct; 42(4):811-7. PubMed ID: 12913063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ETA receptor mediates altered leukocyte-endothelial cell interaction and adhesion molecules expression in DOCA-salt rats.
    Callera GE; Montezano AC; Touyz RM; Zorn TM; Carvalho MH; Fortes ZB; Nigro D; Schiffrin EL; Tostes RC
    Hypertension; 2004 Apr; 43(4):872-9. PubMed ID: 14993193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of gp91phox-containing NADPH oxidase in the deoxycorticosterone acetate-salt-induced hypertension.
    Fujii A; Nakano D; Katsuragi M; Ohkita M; Takaoka M; Ohno Y; Matsumura Y
    Eur J Pharmacol; 2006 Dec; 552(1-3):131-4. PubMed ID: 17064681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
    Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
    Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension.
    Kawanishi H; Hasegawa Y; Nakano D; Ohkita M; Takaoka M; Ohno Y; Matsumura Y
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):280-5. PubMed ID: 17324138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and Pharmacologic Inhibition of the Chemokine Receptor CXCR2 Prevents Experimental Hypertension and Vascular Dysfunction.
    Wang L; Zhao XC; Cui W; Ma YQ; Ren HL; Zhou X; Fassett J; Yang YZ; Chen Y; Xia YL; Du J; Li HH
    Circulation; 2016 Nov; 134(18):1353-1368. PubMed ID: 27678262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of cardiac dysfunction by selective ET-A receptor antagonism.
    Allan A; Fenning A; Levick S; Hoey A; Brown L
    Br J Pharmacol; 2005 Nov; 146(6):846-53. PubMed ID: 16151437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
    Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ
    Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile.
    Sierra-Filardi E; Nieto C; Domínguez-Soto A; Barroso R; Sánchez-Mateos P; Puig-Kroger A; López-Bravo M; Joven J; Ardavín C; Rodríguez-Fernández JL; Sánchez-Torres C; Mellado M; Corbí AL
    J Immunol; 2014 Apr; 192(8):3858-67. PubMed ID: 24639350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.